Association of tumor necrosis factor-α polymorphisms with susceptibility and clinical outcomes of rheumatic heart disease

Saudi Medical Journal

Volumn 31, Issue 6, 2010, Pages 644-649

  Mohamed, Amal A ^a   Rashed, Laila A ^a   Shaker, Saher M ^a   Ammar, Rasha I ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; TUMOR NECROSIS FACTOR ALPHA; PRIMER DNA;

ARTICLE; BLOOD SAMPLING; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATIC HEART DISEASE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; UNIVERSITY HOSPITAL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; NUCLEOTIDE SEQUENCE;

BASE SEQUENCE; CHILD; CROSS-SECTIONAL STUDIES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; RHEUMATIC HEART DISEASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77958040703     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Settin A, Abdel-Hady H, El-Baz R, Saber I. Gene polymorphisms of TNF-alpha(-308), IL-10(-1082), IL-6(-174), and IL-1Ra(VNTR) related to susceptibility and severity of rheumatic heart disease. Pediatr Cardiol 2007; 28: 363-371.
2. Guilherme L, Kalil J. Rheumatic fever: from innate to acquired immune response. Ann N Y Acad Sci 2007; 1107: 426-433.
3. Ramasawmy R, Faé KC, Spina G, Victora GD, Tanaka AC, Palácios SA, et al. Association of polymorphisms within the promoter region of the tumor necrosis factor-alpha with clinical outcomes of rheumatic fever. Mol Immunol 2007; 44: 1873-1888.
4. Hounie AG, Cappi C, Cordeiro Q, Sampaio AS, Moraes I, Rosário MC, et al. TNF-alpha polymorphisms are associated with obsessive-compulsive disorder. Neurosci Lett 2008; 442: 86-90.
5. Quinn A, Kosanke S, Fischetti VA, Factor SM, Cunningham MW. Induction of autoimmune valvular heart disease by recombinant streptococcal m protein. Infect Immun 2001; 69: 4072-4078.
6. Guilherme L, Cury P, Demarchi LM, Coelho V, Abel L, Lopez AP, et al. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol 2004; 165: 1583-1591.
7. Ferguson LR, Huebner C, Petermann I, Gearry RB, Barclay ML, Demmers P, et al. Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J Gastroenterol 2008; 14: 4652-4661.
8. Working Group on Pediatric Acute Rheumatic Fever and Cardiology Chapter of Indian Academy of Pediatrics, Saxena A, Kumar RK, Gera RP, Radhakrishnan S, Mishra S, Ahmed Z. Consensus guidelines on pediatric acute rheumatic fever and rheumatic heart disease. Indian Pediatr 2008; 45: 565-573.
9. Noguera NI, Tallano CE, Bragós IM, Milani AC. Modified salting-out method for DNA isolation from newborn cord blood nucleated cells. J Clin Lab Anal 2000; 14: 280-283.
10. Migot-Nabias F, Mombo LE, Luty AJ, Dubois B, Nabias R, Bisseye C, et al. Human genetic factors related to susceptibility to mild malaria in Gabon. Genes Immun 2000; 1: 435-441.
11. Sallakci N, Akcurin G, Köksoy S, Kardelen F, Uguz A, Coskun M, et al. TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production. J Autoimmun 2005; 25: 150-154.
12. Hernandez-Pacheco G, Flores-Dominguez C, Rodriguez-Perez JM, Perez-Hernandez N, Fragoso JM, Saul A, et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun 2003; 21: 59-63.
13. Berdeli A, Tabel Y, Celik HA, Ozyürek R, Dogrusoz B, Aydin HH. Lack of association between TNFalpha gene polymorphism at position-308 and risk of acute rheumatic fever in Turkish patients. Scand J Rheumatol 2006; 35: 44-447.
14. Kudat H, Telci G, Sozen AB, Oguz F, Akkaya V, Ozcan M, et al. The role of HLA molecules in susceptibility to chronic rheumatic heart disease. Int J Immunogenet 2006; 33: 41-44.
15. Finan RR, Al-Irhayim Z, Mustafa FE, Al-Zaman I, Mohammed FA, Al-Khateeb GM, et al. Tumor necrosis factor-alpha polymorphisms in women with idiopathic recurrent miscarriage. J Reprod Immunol 2010; 84: 186-192.
16. Zammiti W, Mtiraoui N, Khairi H, Gris JC, Almawi WY, Mahjoub T. Associations between tumor necrosis factoralpha and lymphotoxin-alpha polymorphisms and idiopathic recurrent miscarriage. Reproduction 2008; 135: 397-403.
17. Gorbunov VV, Tsarenok SIu, Rosin IV. [Lymphocyticthrombocytic adhesion and production of blood serum cytokines in rheumatic heart disease] Ter Arkh 2008; 80: 37-39. Russian.
18. Lu MC, Yang KL, Tung CH, Huang KY, Yu HC, Liu SQ, et al. Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with-308G/A polymorphism in promoter region of tumor necrosis factor: association with distinct A33/B58/Cw10 haplotypes. Rheumatol Int 2008; 29: 189-195.
19. Yoon SZ, Jang IJ, Choi YJ, Kang MH, Lim HJ, Lim YJ, et al. Association between tumor necrosis factor alpha 308G/A polymorphism and increased proinflammatory cytokine release after cardiac surgery with cardiopulmonary bypass in the Korean population. J Cardiothorac Vasc Anesth 2009; 23: 646-650.
20. Haddy N, Sass C, Maumus S, Marie B, Droesch S, Siest G et al. Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort. Eur J Hum Genet 2005; 13: 109-117.
21. Escobar-Morreale HF, Calvo RM, Sancho J, San Millán JL. TNF-alpha and hyperandrogenism: a clinical, biochemical, and molecular genetic study. J Clin Endocrinol Metab 2001; 86: 3761-3767.
22. Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Frostegård J, Wiman B, et al. Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis 2006; 187: 408-414.
23. Hajeer AH, Hutchinson IV. TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech 2000; 50: 216-228.
24. Bayley JP, de Rooij H, van den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the-376,-308,-244, and-238 polymorphic sites of the TNF-alpha promoter. Cytokine 2001; 14: 316-323.
25. Hu ZW, Luo HB, Xu YM, Guo JW, Deng XL, Tong YW, et al. Tumor necrosis factor--alpha gene promoter polymorphisms in Chinese patients with nonalcoholic fatty liver diseases. Acta Gastroenterol Belg 2009; 72: 215-221.
26. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, et al. Different transcriptional activity and in vitro TNFalpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 2000; 114: 1180-1183.
27. Konuk N, Tekin IO, Ozturk U, Atik L, Atasoy N, Bektas S, et al. Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediators Inflamm 2007; 2007: 65704.